Uterine and Endometrial Volume in PCOS and HPOD
Key facts
- Who runs it
- Jagiellonian University
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 648 people enrolled
- Started
- 5 Jan 2024
- Ended
- 31 Dec 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Two-dimensional and three-dimensional ultrasound of the female reproductive organ
- Record updated
- 19 March 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- age 18-45 years
- no previous diagnosis and treatment due to menstrual disorders or infertility
Who cannot take part
- previous ovarian surgery
- use of drugs that disturb the functions of the hypothalamic-pituitary-ovarian axis
- uterine tumors
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). Assessment of ovarian volume, number and morphology of ovarian follicles is essential in the diagnosis of menstrual disorders, including PCOS and HPOD. However, the uterus is a target organ for steroid hormones, and the assessment of uterine size and endometrial morphology may also be of clinical importance. While ultrasonographic features of the ovaries in PCOS have been described and constitute one of the diagnostic criteria for the syndrome (Rotterdam criteria), there is little data on uterine volume in women with PCOS and HPOD. The aim is to compare ultrasound i) uterine volume and ii) endometrial volume among women with PCOS and women with HPOD.
The 2 groups in the trial
- Arm 1
Polycystic ovary syndrome (PCOS)
Treatment: Two-dimensional and three-dimensional ultrasound of the female reproductive organ
- Arm 2
Hypothalamic-pituitary-ovarian axis dysfunction (HPOD)
Treatment: Two-dimensional and three-dimensional ultrasound of the female reproductive organ
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ultrasound Assessment of Uterine and Endometrium Volume in Women With PCOS and HPOD
- Record updated
- 19 March 2026